Reporter for Labiotech. I hail from the UK. I was born in Bristol, studied Neuroscience in the University of Bristol, and trained mice in Eisai, Hertfordshire, for one year. I then tickled locusts for my Ph.D. at the University of Leicester, before eventually ending up here!
Out of the office, I travel, play video games and board games, drink beer and play the piano.

Articles by Jonathan Smith

4BIO Capital Raises €45M Fund to Invest in Advanced Therapies

Startup Scout 6 Sep 2019

This Biotech Regenerates Bone Tissue to Treat Tooth Loss

Top Cardiology Biotech News from the ESC Conference 2019

US Genomics Firm Combines with Curetis to Tackle Antibiotic Resistance

Interview 4 Sep 2019

Overcoming Clinical Setbacks to Fight Insect-Borne Diseases

UK Biotech’s Personalized Immunotherapy gets €110M Series B Boost

Startup Scout 30 Aug 2019

This Biotech Develops Epigenetic Drugs to Fight Brain Cancer

HiFiBiO’s €60M Series C to Fund Cancer and Autoimmune Disease Antibody Drugs

Off-the-Shelf Kidney Cancer Immunotherapy More Than Doubles Recovery in Phase II

Type 1 Diabetes Immunotherapy Shows Promise in Phase I

Celgene and Immatics Sign Deal Worth Over €1.35B to Develop Cancer Immunotherapies

Swedish Ulcerative Colitis Treatment Makes Phase II Comeback